Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionCNB Bank
Latest Disclosed Ownership6,746 shares
Latest Disclosed Value $ 409,145
CNB Bank reports 1.65% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 6, 2026 - CNB Bank filed a 13F-HR form disclosing ownership of 6,746 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $353,625 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 6,859 shares of Bristol-Myers Squibb Company. This represents a change in shares of -1.65% during the quarter. The current value of the position is $319,997 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,746 -113 -1.65 409 10.84 0.1721
2026-02-11 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,859 -632 -8.44 370 9.50 0.1514
2025-10-30 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 7,491 1,350 21.98 338 18.66 0.1408
2025-07-31 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,141 -150 -2.38 284 -25.85 0.1348
2025-04-24 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,291 -548 -8.01 384 -0.78 0.1942
2025-01-15 2024-12-31 13F BRISTOL-MYRS SQUIB COM 110122108 6,839 -410 -5.66 387 2.93 0.1797
2024-10-18 2024-09-30 13F BRISTOL-MYRS SQUIB COM 110122108 7,249 -500 -6.45 375 16.82 0.1735
2024-08-08 2024-06-30 13F BRISTOL-MYRS SQUIB COM 110122108 7,749 -822 -9.59 322 -30.82 0.1548
2024-05-02 2024-03-31 13F BRISTOL-MYRS SQUIB COM 110122108 8,571 -430 -4.78 465 0.65 0.2267
2024-01-31 2023-12-31 13F BRISTOL-MYRS SQUIB COM 110122108 9,001 -105 -1.15 462 -12.69 0.2480
2023-11-02 2023-09-30 13F BRISTOL-MYRS SQUIB COM 110122108 9,106 317 3.61 529 -6.05 0.3112
2023-08-08 2023-06-30 13F BRISTOL-MYRS SQUIB COM 110122108 8,789 489 5.89 562 -2.26 0.3306
2023-05-10 2023-03-31 13F BRISTOL-MYRS SQUIB COM 110122108 8,300 -150 -1.78 575 -5.27 0.3501
2023-02-13 2022-12-31 13F BRISTOL-MYRS SQUIB COM 110122108 8,450 -160 -1.86 608 -0.82 0.3801
2022-11-14 2022-09-30 13F BRISTOL-MYRS SQUIB COM 110122108 8,610 -434 -4.80 612 -12.07 0.4141
2022-08-19 2022-06-30 13F/A-1 BRISTOL-MYRS SQUIB COM 110122108 9,044 -417 -4.41 696 0.72 0.4502
2022-08-10 2022-06-30 13F BRISTOL-MYRS SQUIB COM 110122108 14,926 5,465 1,149 0.4737
2022-04-13 2022-03-31 13F Bristol-Myers Squibb COM 110122108 9,461 -475 -4.78 691 11.45 0.3830
2022-01-31 2021-12-31 13F Bristol-Myers Squibb COM 110122108 9,936 -183 -1.81 620 3.51 0.3397
2021-11-02 2021-09-30 13F Bristol-Myers Squibb COM 110122108 10,119 -406 -3.86 599 -14.79 0.3598
2021-07-29 2021-06-30 13F Bristol-Myers Squibb COM 110122108 10,525 170 1.64 703 7.49 0.4396
2021-05-03 2021-03-31 13F Bristol-Myers Squibb COM 110122108 10,355 -60 -0.58 654 1.24 0.4525
2021-01-27 2020-12-31 13F Bristol-Myers Squibb COM 110122108 10,415 -408 -3.77 646 -1.07 0.4879
2020-10-26 2020-09-30 13F Bristol-Myers Squibb COM 110122108 10,823 -3,031 -21.88 653 -19.88 0.5496
2020-07-14 2020-06-30 13F Bristol-Myers Squibb COM 110122108 13,854 -899 -6.09 815 -0.85 0.7173
2020-05-13 2020-03-31 13F Bristol-Myers Squibb COM 110122108 14,753 -2,043 -12.16 822 -23.75 0.8855
2020-01-27 2019-12-31 13F Bristol-Myers Squibb COM 110122108 16,796 1,535 10.06 1,078 39.28 0.9126
2019-11-04 2019-09-30 13F Bristol-Myers Squibb COM 110122108 15,261 -2,284 -13.02 774 -2.76 0.7164
2019-08-14 2019-06-30 13F Bristol-Myers Squibb COM 110122108 17,545 -1,314 -6.97 796 -11.56 0.6793
2019-04-29 2019-03-31 13F Bristol-Myers Squibb COM 110122108 18,859 1,517 8.75 900 -0.22 0.4635
2019-02-06 2018-12-31 13F Bristol Myers Squibb Co Com COM 110122108 17,342 732 4.41 902 -12.51 0.5747
2018-11-13 2018-09-30 13F Bristol Myers Squibb Co Com COM 110122108 16,610 -482 -2.82 1,031 8.99 0.5899
2018-08-14 2018-06-30 13F Bristol Myers Squibb Co Com COM 110122108 17,092 -136 -0.79 946 -13.13 0.5510
2018-05-11 2018-03-31 13F Bristol Myers Squibb Co Com COM 110122108 17,228 1,728 11.15 1,089 14.63 0.6362
2018-02-20 2017-12-31 13F Bristol Myers Squibb Co Com COM 110122108 15,500 15,500 950 0.5681
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.